This study found that hair loss following COVID-19 infection was frequently observed, especially in women, and awareness of post-COVID-19 acute telogen effluvium was generally low.
48 citations
,
November 2022 in “Journal of Cosmetic Dermatology” This review discusses various skin manifestations associated with COVID-19, emphasizing their potential role in early diagnosis and management of the infection, but reports no new clinical findings.
6 citations
,
May 2022 in “Frontiers in Medicine” This study observed that COVID-19-related stress and fear were potentially associated with an increased occurrence of hair diseases like telogen effluvium, alopecia areata, and seborrheic dermatitis among medical students in Bangladesh.
25 citations
,
February 2022 in “JAAD International” This review analyzed data on alopecia types associated with COVID-19, suggesting androgenetic alopecia may be a risk factor for severe COVID-19, while telogen effluvium often follows infection and alopecia areata tends to relapse in those with preexisting disease.
18 citations
,
November 2021 in “Anais Brasileiros de Dermatologia” This review examines the skin manifestations associated with COVID-19 but reports no new clinical findings, emphasizing the need for differential diagnoses to correlate skin symptoms with the virus.
22 citations
,
October 2021 in “Dermatologic Therapy” This study found that approximately one-quarter of post-COVID-19 patients experienced telogen effluvium, with a higher incidence among women, hospitalized patients, and those with hypertension or respiratory symptoms.
1 citations
,
October 2021 in “PubMed” This case report describes a 43-year-old woman with scarring burn alopecia treated with tissue expansion and local flap reconstruction, who experienced reversible acute hair loss (Telogen Effluvium) after the procedure.
39 citations
,
August 2021 in “JAAD International” This study found that telogen effluvium and trichodynia are common in patients after COVID-19, and their severity may be influenced by the severity of the COVID-19 infection.
2 citations
,
August 2021 in “Canadian Family Physician” This review examines the increase in dermatologic conditions related to COVID-19, highlighting direct viral effects, PPE-related issues, and stress-related exacerbations, but reports no new clinical findings.
32 citations
,
July 2021 in “Journal of The American Academy of Dermatology” This study found that acute telogen effluvium after COVID-19 typically began about 1.5 months post-infection and resolved sooner than typical cases, with most resolving in under two months.
7 citations
,
June 2021 in “JAAD Case Reports” This article reviews the cutaneous manifestations of COVID-19, highlighting their potential as early indicators of infection, and reports no new clinical results.
4 citations
,
March 2021 in “International Journal of Dermatology” COVID-19 and related stress may increase hair loss known as Telogen effluvium.
82 citations
,
June 2020 in “Inflammation Research” This review discusses the complex pathophysiological and clinical aspects of COVID-19, including dermatological findings and their association with SARS-CoV-2 infection but reports no new clinical results.
176 citations
,
May 2020 in “Dermatologic Therapy” This review discusses the cutaneous symptoms associated with COVID-19 and their potential use in diagnosing and assessing the severity of the disease, but it reports no new clinical results.
